No abstract

Obesity is a complex pathology that affects virtually all stages of life, regardless of socioeconomic groups. GLP-1 analogues are potentially promising drugs for weight loss in obese or overweight adults and at least one comorbidity. An integrative review of the use of the GLP-1 analogue semaglutide in the treatment of obesity and weight loss therapy was reviewed, analyzing the STEP (Semaglutide Treatment Effect in People with Obesity) study.

Mato Grosso is an endemic region for leprosy. There are patients who, even after treating the disease, present recurrence, which can be classified as paucibacillary or multibacillary relapsing. Recurrent patients present impairment of organic functions, new lesions and/or worsening of previous lesions and do not respond to the use of usual medications. Diagnosing people with recurrence of leprosy is important because of the recurrence of this event. The present study reports the case of a patient treated in the public health sector, with relapse of leprosy, with treatment and follow-up of the case being carried out.